These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31330366)

  • 1. Molecular pathogenesis of gallbladder cancer: An update.
    Mishra SK; Kumari N; Krishnani N
    Mutat Res; 2019 Nov; 816-818():111674. PubMed ID: 31330366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis.
    Khandelwal A; Malhotra A; Jain M; Vasquez KM; Jain A
    Biochimie; 2017 Jan; 132():152-160. PubMed ID: 27894946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay.
    Doghish AS; Radwan AF; Zaki MB; Elfar N; Moussa R; Walash Z; Alhamshry NAA; Mohammed OA; Abdel-Reheim MA; Elimam H
    Int J Biol Macromol; 2024 Apr; 264(Pt 1):130426. PubMed ID: 38428766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.
    Montalvo-Jave EE; Rahnemai-Azar AA; Papaconstantinou D; Deloiza ME; Tsilimigras DI; Moris D; Mendoza-Barrera GE; Weber SM; Pawlik TM
    Surg Oncol; 2019 Dec; 31():83-89. PubMed ID: 31541911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis.
    Gupta RK; Bhushan R; Kumar S; Prasad SB
    Sci Rep; 2024 Jun; 14(1):14570. PubMed ID: 38914609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review with in silico analysis on transcriptomic profile of gallbladder carcinoma.
    Tulsyan S; Hussain S; Mittal B; Saluja SS; Tanwar P; Rath GK; Goodman M; Kaur T; Mehrotra R
    Semin Oncol; 2020 Dec; 47(6):398-408. PubMed ID: 33162112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
    Zhou N; Cheng W; Peng C; Liu Y; Jiang B
    Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging roles of long non-coding RNA in gallbladder cancer tumorigenesis.
    Chen B; Li Y; He Y; Xue C; Xu F
    Cancer Biomark; 2018; 22(3):359-366. PubMed ID: 29758925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
    Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
    Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biomarkers for the diagnosis and prognosis of gallbladder cancer.
    Lin HZ; Zhang T; Chen MY; Shen JL
    J Dig Dis; 2021 Feb; 22(2):62-71. PubMed ID: 33369216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
    Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
    Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
    Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
    Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation as an epigenetic regulator of gallbladder cancer: An overview.
    Muhammad JS; Khan MR; Ghias K
    Int J Surg; 2018 May; 53():178-183. PubMed ID: 29602013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.
    Sicklick JK; Fanta PT; Shimabukuro K; Kurzrock R
    Cancer Metastasis Rev; 2016 Jun; 35(2):263-75. PubMed ID: 26857926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
    Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
    J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
    Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
    Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance.
    Shahin RK; Elkady MA; Abulsoud AI; Abdelmaksoud NM; Abdel Mageed SS; El-Dakroury WA; Zewail MB; Elazazy M; Sobhy MH; Nomier Y; Elazazy O; Elballal MS; Mohammed OA; Midan HM; Elrebehy MA; Ziada BO; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154684. PubMed ID: 37454489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.